Table 3.
Cases (N=300) | Controls (N=300) | OR | 95% CI | P-value | |
---|---|---|---|---|---|
CTDSP1 | |||||
Q1 | 65 | 89 | 1.0 | ||
Q2 | 77 | 70 | 1.5 | (0.96-2.4) | |
Q3 | 77 | 75 | 1.4 | (0.90-2.2) | |
Q4 | 81 | 66 | 1.7 | (1.1 -2.6) | |
P trend | 0.04 | ||||
MAPK9 | |||||
Q1 | 61 | 91 | 1.0 | ||
Q2 | 69 | 77 | 1.3 | (0.84-2.1) | |
Q3 | 80 | 77 | 1.5 | (0.98-2.5) | |
Q4 | 90 | 55 | 2.4 | (1.5 -3.9) | |
P trend | 0.0002 | ||||
NR2E3 | |||||
Q1 | 50 | 89 | 1.0 | ||
Q2 | 76 | 85 | 1.6 | (1.0 -2.5) | |
Q3 | 71 | 79 | 1.6 | (1.0 -2.6) | |
Q4 | 103 | 47 | 4.0 | (2.4 -6.5) | |
P trend | <0.0001 | ||||
CTDSP1 | |||||
<Q4 | 219 | 234 | 1.0 | ||
Q4 | 81 | 66 | 1.3 | (0.90-1.9) | |
0.15 | |||||
MAPK9 | |||||
<Q4 | 210 | 245 | 1.0 | ||
Q4 | 90 | 55 | 1.9 | (1.3 -2.8) | |
0.0009 | |||||
NR2E3 | |||||
<Q4 | 197 | 253 | 1.0 | ||
Q4 | 103 | 47 | 2.9 | (1.9 -4.3) | |
<0.0001 | |||||
No. of AAs with levels in Q4 | |||||
0 (none) | 158 | 198 | 1.0 | (referent) | |
1 of 3 | 55 | 55 | 1.2 | (0.81-1.9) | |
2 of 3 | 42 | 28 | 1.9 | (1.1 - 3.2) | |
3 of 3 | 45 | 19 | 3.0 | (1.7 -5.4) | |
P trend | 1.4 | (1.2 -1.7) | <0.0001 |
* Autoantibody serum level fit as a continuous variable in age and sex-adjusted logistic model
Q4 = 4th quartile, AAs= autoantibodies